Antimicrobial Resistance Centre

Inspiring innovation in AMR research through interdisciplinary and international engagements.

Book Launch and Panel Discussion | Superbugs: An Arms Race against Bacteria


Further speakers to be added


Date: Thursday 26 April

Time: 17:30 – 19:00

Venue: John Snow Lecture Theatre, Keppel Street

Following the talk and panel discussion, a book sales and signing will take place in the South Courtyard Café.

Superbugs will be available to purchase at the event (cash and card) for the special price of £15.

Find out more.

Upcoming seminars

Seminar | The new Sustainable Development Goals and Access to Essential Medicine


The Honourable Michael Kirby AC CMG will deliver this special Seminar entitled ‘The new Sustainable Development Goals and Access to Essential Medicines’.

First appointed a judge in 1975, he ultimately served on the High Court of Australia, the nation’s Federal Supreme Court, 1996-2009. Since his retirement from judicial office in 2009, he has literally been busier than ever. In 2010-11, he served on the Eminent Persons Group on the future of the Commonwealth of Nations. In 2011-12, on the United Nations Development Programme (UNDP) Global Commission on HIV and the Law. In 2013-14 as chair of the United Nations Human Rights Council’s commission of inquiry on human rights abuses in North Korea. In 2015-16 as a member of the UN Secretary General’s high-level panel on access to essential medicines. He has just been appointed as a member of a new initiative of UNDP on Global Judicial Integrity. He is in London for a series of lectures on rogue states and North Korea; on SDGs and access to essential medicines; and on LGBTIQ rights in Australia.


Speaker: The Honourable Michael Kirby AC CMG, UNDP

Date: Tuesday 20 March 2018

Time: 13:00 – 14:00

Venue: Manson Lecture Theatre, Keppel Street

About the Antimicrobial Resistance (AMR) Centre

AMR is a threat to life and healthcare globally. With increasing levels of international concern about AMR, we need high quality research and evidence to guide action. The London School of Hygiene & Tropical Medicine is unique in the breadth of disciplines used to meet this complex challenge. These range from microbiology and clinical medicine to social studies and economics. The School’s Antimicrobial Resistance Centre, launched in 2016, will foster connections between these scientific approaches, generating innovative approaches to science and policy.

The Centre is based on five disciplinary pillars:

The aims of the AMR Centre are:

  1. Promote and facilitate high quality research into AMR that builds on and exploits disciplinary strengths across LSHTM.
  2. Facilitate AMR related funding responses and collaboration opportunities.
  3. Provide an interface for LSHTM’s AMR research for staff, public, press and wider research communities.
  4. Provide educational materials on AMR.

Spotlight 05/02/18 | Global Antimicrobial Resistance Surveillance System (GLASS)

This week, the Global Antimicrobial Resistance Surveillance System (GLASS) published their report: (Early Implementation 2016-17) detailing the participation efforts and initial outcomes across the 52 countries currently enrolled. Glass was launched in October 2015 to support the global action plan on antimicrobial resistance.

Official national AMR data are collated for Acinetobacter spp., Escherichia coliKlebsiella pneumoniaeNeisseria gonorrhoeaeSalmonella spp., Shigella spp., Staphylococcus aureus, and Streptococcus pneumoniae.

Read more.

Metrics and Methods for Assessing Antibiotic Use – Roundtable

In late November 2017, the AMR Centre hosted 38 researchers, health and policy professionals in London for a roundtable to discuss how best antibiotic use can be measured in a way that informs strategies to address antibiotic resistance both nationally and internationally.

Read about the roundtable discussion here.

VIDEO | Rise and fall of the magic bullet

AMR Centre member Sam Willcocks walks us through the rise and fall of antibiotics, and shows us why we need to think carefully about how we harness new technology so that we can continue to do good.